Core Laboratories N.V. (CLB)
Core Laboratories Statistics
Share Statistics
Core Laboratories has 46.83M shares outstanding. The number of shares has increased by 0.2% in one year.
| Shares Outstanding | 46.83M |
| Shares Change (YoY) | 0.2% |
| Shares Change (QoQ) | 0.08% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 46.35M |
| Failed to Deliver (FTD) Shares | 1K |
| FTD / Avg. Volume | 0.3% |
Short Selling Information
The latest short interest is 6.2M, so 13.2% of the outstanding shares have been sold short.
| Short Interest | 6.2M |
| Short % of Shares Out | 13.2% |
| Short % of Float | 13.33% |
| Short Ratio (days to cover) | 18.92 |
Valuation Ratios
The PE ratio is 26.29 and the forward PE ratio is 19.15. Core Laboratories's PEG ratio is -1.6.
| PE Ratio | 26.29 |
| Forward PE | 19.15 |
| PS Ratio | 1.58 |
| Forward PS | 1.1 |
| PB Ratio | 8.74 |
| P/FCF Ratio | 19.04 |
| PEG Ratio | -1.6 |
Enterprise Valuation
Core Laboratories N.V. has an Enterprise Value (EV) of 1.02B.
| EV / Earnings | 32.63 |
| EV / Sales | 1.96 |
| EV / EBITDA | 13.94 |
| EV / EBIT | 17.5 |
| EV / FCF | 23.63 |
Financial Position
The company has a current ratio of 0.02, with a Debt / Equity ratio of 1.91.
| Current Ratio | 0.02 |
| Quick Ratio | 0 |
| Debt / Equity | 1.91 |
| Total Debt / Capitalization | 65.6 |
| Cash Flow / Debt | 0.31 |
| Interest Coverage | 4.73 |
Financial Efficiency
Return on equity (ROE) is 0.33% and return on capital (ROIC) is 14.54%.
| Return on Equity (ROE) | 0.33% |
| Return on Assets (ROA) | 0.05% |
| Return on Capital (ROIC) | 14.54% |
| Revenue Per Employee | $149,670.86 |
| Profits Per Employee | $8,971.43 |
| Employee Count | 3,500 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 260.3 |
Taxes
| Income Tax | 14.03M |
| Effective Tax Rate | 0.3 |
Stock Price Statistics
The stock price has increased by -6.46% in the last 52 weeks. The beta is 2.39, so Core Laboratories's price volatility has been higher than the market average.
| Beta | 2.39 |
| 52-Week Price Change | -6.46% |
| 50-Day Moving Average | 17.27 |
| 200-Day Moving Average | 19 |
| Relative Strength Index (RSI) | 39.51 |
| Average Volume (20 Days) | 334.31K |
Income Statement
In the last 12 months, Core Laboratories had revenue of 523.85M and earned 31.4M in profits. Earnings per share was 0.66.
| Revenue | 523.85M |
| Gross Profit | 88.37M |
| Operating Income | 58.56M |
| Net Income | 31.4M |
| EBITDA | 73.51M |
| EBIT | 58.56M |
| Earnings Per Share (EPS) | 0.66 |
Balance Sheet
The company has 19.16M in cash and 180.14M in debt, giving a net cash position of -160.99M.
| Cash & Cash Equivalents | 19.16M |
| Total Debt | 180.14M |
| Net Cash | -160.99M |
| Retained Earnings | 0 |
| Total Assets | 590.41M |
| Working Capital | 129.02M |
Cash Flow
In the last 12 months, operating cash flow was 56.39M and capital expenditures -13.03M, giving a free cash flow of 43.36M.
| Operating Cash Flow | 56.39M |
| Capital Expenditures | -13.03M |
| Free Cash Flow | 43.36M |
| FCF Per Share | 0.91 |
Margins
Gross margin is 16.87%, with operating and profit margins of 11.18% and 5.99%.
| Gross Margin | 16.87% |
| Operating Margin | 11.18% |
| Pretax Margin | 8.82% |
| Profit Margin | 5.99% |
| EBITDA Margin | 14.03% |
| EBIT Margin | 11.18% |
| FCF Margin | 8.28% |
Dividends & Yields
CLB pays an annual dividend of $0.05, which amounts to a dividend yield of 0.23%.
| Dividend Per Share | $0.05 |
| Dividend Yield | 0.23% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 7.58% |
| Earnings Yield | 4.43% |
| FCF Yield | 6.21% |
Analyst Forecast
The average price target for CLB is $16, which is 7.3% higher than the current price. The consensus rating is "Hold".
| Price Target | $16 |
| Price Target Difference | 7.3% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Jul 9, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 9, 2010 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 2.62 |
| Piotroski F-Score | 7 |